08/14/2025
10:00 AM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
08/13/2025
4:41 PM | Avadel Pharmaceuticals (Subject)
Two Seas Capital LP (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
8:21 AM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
6:07 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
6:02 PM | Avadel Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/14/2025
11:31 AM | ASL Strategic Value Fund, LP (Filed by)
Avadel Pharmaceuticals (Subject)
| Form PX14A6G | |
06/30/2025
9:56 AM | ASL Strategic Value Fund, LP (Filed by)
Avadel Pharmaceuticals (Subject)
| Form PX14A6G | |
06/18/2025
6:01 AM | Avadel Pharmaceuticals (Filer)
| Form DEF 14A | |
06/18/2025
6:03 AM | Avadel Pharmaceuticals (Filer)
| Form DEFA14A | |
06/18/2025
6:05 AM | Avadel Pharmaceuticals (Filer)
| Form ARS | |
06/05/2025
6:34 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AVDL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
11:00 AM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
5:00 PM | Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2025
5:01 PM | Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
3:22 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
8:20 AM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:07 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
1:59 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
2:01 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
3:45 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
8:16 AM | Avadel Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/03/2025
6:09 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
10:55 AM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
01/28/2025
3:22 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:22 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:24 PM | Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:18 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
3:15 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:20 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:13 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:14 PM | Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:02 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
10:50 AM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:10 AM | Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
4:58 PM | Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024
6:06 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:07 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
9:34 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad) For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026.
If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest. Click here to get your free advisor matches and start planning your legacy today. |
09/16/2024
4:18 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:01 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
6:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
6:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access